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User Testing to Improve Retrieval and Comprehension of
Information in Guidelines to Improve Medicines Safety
Matthew D. Jones, PhD,* Bryony Dean Franklin, PhD,†Margaret C. Watson, PhD,*‡ and DK Raynor, PhD§||
Objective: The aim of the study was to investigate the effectiveness of
user testing for improving healthcare professionals’ retrieval and compre-
hension of information in medicines guidelines.
Methods: The United Kingdom’s Injectable Medicines Guide was se-
lected as a case study. This gives guidance to nurses on preparing and ad-
ministering intravenous medicines on hospital wards, in line with standard
UK practice. Three rounds of user testing were completed with 10 hospital
nurses per round, using the Injectable Medicines Guide for voriconazole
and aminophylline. Participants used the guidelines to answer 17 questions
related to the administration of these medicines. Answers were scored for
“finding” and “understanding” the required information. Semistructured
interviews explored participants’ opinions of guideline content, design,
andwording, with responses analyzed thematically. The guidelineswere re-
vised between rounds.
Results: In round 1, 8 of 17 questions were answered correctly by
all participants. Participants had difficulty with dose, dilution, ad-
ministration rate, and adverse effects questions. Revisions included
new subsections and increased calculation support. In round 2, 14
of 17 questions were answered correctly by all participants. Diffi-
culty persisted with dose and administration rate questions and fur-
ther revisions made. In round 3, 15 of 17 questions were answered
correctly by all participants. Across all rounds, participants considered ap-
propriate subheadings and information order as important for fast location
of information. Specific, detailed, and practical instructions were perceived
as important to improve understandability and usefulness.
Conclusions: Key information in medicines guidelines may not be found
and/or understood by healthcare professionals. User testing increased in-
formation retrieval and comprehension and could have an important role
in improving the safety of medicines use.
Key Words: guidelines, medicines safety, medication errors, user testing,
information design, intravenous, injectable medicines, nurses, usability,
user experience
(J Patient Saf 2020;00: 00–00)
A pproximately 237million medication errors occur in Englandeach year, of which 28% have potential to cause patient
harm.1 The resultant additional inpatient admissions and increased
hospital length of stay costs the National Health Service (NHS) at
least £98 million per year.1 Internationally, the cost of unsafe med-
ication practice and errors is estimated to be U.S. $42 billion.2 The
risk of medication errors is higher for intravenous medicines than for
other routes of administration, with 30% to 50%of intravenous doses
involving an error.3,4 In 2017, the World Health Organization
launched its third Global Patient Safety Challenge: Medication
Without Harm, to reduce severe avoidable medication-related
harm by 50% over 5 years.2
Written guidance for health professionals that is contradictory,
incomprehensible, or of poor quality is one of many potential
causes of medication errors.5,6 In particular, difficulty finding rel-
evant, unambiguous information in technical documents has been
linked to serious medication errors.7–10 There is little empirical ev-
idence of the effectiveness of tools to prepare and test medicines
guidelines for use by health professionals in the clinical environ-
ment. Only one study was identified, which used user testing with
doctors to improve the presentation of the Summaries of Product
Characteristics (SPCs) for 2medicines, which increased the amount
of information found and understood.11
User testing is based on the performance of a document in
the hands of potential users, assessing whether people can
find and understand the information they need.12 Problems
and potential solutions are therefore identified. Iterative
rounds of interviews with potential users are followed by doc-
ument revision, until all issues are resolved.11–13 Each inter-
view involves closed questions to determine whether the
interviewee can locate and understand key information, followed
by a semistructured interview to explore opinions of general is-
sues. The validity of these opinions is enhanced by the fact that
the participants have actually had to use the information (in a sim-
ulated situation).
User testing has been shown to improve understanding and de-
crease reading time of patient-facing medicines information, evi-
dence summaries, and infection control guidelines.12,14–16 It is
recommended for the implementation of clinical guidelines17 and
is required for patient information leaflets for licensed medicines.12
However, because of lack of evidence, it is unclear whether user
testing is effective in improving medicines guidance written for
health professionals in the clinical environment.
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Therefore, the aim of this study was to investigate the effective-
ness of user testing for improving healthcare professionals’ retrieval
and comprehension of information in medicines guidelines. The
UK’s NHS Injectable Medicines Guide (IMG)18 was selected as
a case study. This Web site provides guidance on the preparation
and administration of intravenous medicines. In the United
Kingdom, nurses prepare and administer most intravenous doses
on hospital wards, and in more than 120 hospitals, they use the
IMG as a source of information on how to do this. Where these
hospitals use electronic prescribing and medicines administration
systems, the IMG can also be integrated to give guidance from
within the electronic system. However, 2 small surveys (1 of 145
hospitals across the United Kingdom, another of 11 hospitals in
the southwest of England) have suggested the IMG is too detailed
and confusing for some users.19,20 It is therefore a suitable case
study for investigating the impact of user testing, especially given
the increased risk of medication errors associated with intravenous
administration.3,4 Therefore, the specific objective was to examine
the effectiveness of user testing by nurses as a method of improving
retrieval and comprehension of information from the IMG.
METHODS
Three iterative rounds of user testing with hospital nurses were
completed, each followed by document revision.11–13 To ensure
that all aspects of the participants’ experiences were explored, this
was underpinned by Rosenbaum’s user experience framework,
which was developed to describe user experience of documents
used in the development of evidence-based clinical guidelines.21
It describes 8 facets of a user’s experience of a document
(Table 1). The design, implementation, and analysis of the
study were informed by regular discussion with a multidisci-
plinary advisory group of hospital and community nurses, doc-
tors, and pharmacists.
Participants
Included participants were nurses/midwives registered with the
Nursing and Midwifery Council, who were authorized to prepare
and administer intravenous medicines and had done so during at
least 50% of shifts during the past 6 months. They were recruited
from 3 NHS hospitals. At hospitals 1 and 2, the IMG was rou-
tinely used during intravenous medicines administration, but not
at hospital 3.
Ten new participants took part in each round of user testing.
This sample size is based on standard user testing methodology.11–13
As this is a form of diagnostic testing (establishing where docu-
ments do not work), a formal sample size calculation was not con-
sidered appropriate13,22; experience shows that most significant
flaws are identified by the first few participants.13 Participants
were purposefully sampled for each round to include a range of
nursing experience (<5 and ≥5 years’ accreditation to prepare
and administer intravenous medicines) and hospitals.
Selection of Intravenous Medicines Guidelines for
User Testing
Two current IMG guidelines were selected for testing:
voriconazole and aminophylline. This selection was informed by
a pilot study and input from the advisory group. Selection criteria
were guidelines for high-risk medicines that collectively describe
a variety of intravenous procedures, including reconstitution, dilu-
tion, and both short and continuous infusions. To minimize partic-
ipants’ use of prior knowledge, the guidelines were anonymized
by renaming the drugs “bathicillin” and “unimycin” (Supplemen-
tary File 1, http://links.lww.com/JPS/A329). The guidelines were
presented to participants on a tablet computer.
User Testing Procedure
User testing took place in a private, nonclinical setting. An inter-
view schedule (Supplementary File 2, http://links.lww.com/JPS/
A330) was prepared based on published user testing research,11–13
the Rosenbaum user experience framework.21 and the selected IMG
guidelines. After introductory questions, each interview began with
closed questions to determine whether the participant could locate
and interpret 17 of the most important points of information in
the IMG guidelines (Table 2). If necessary, the interviewer used
nonleading prompts that did not assist participants in locating and
interpreting information, such as repeating or clarifying the ques-
tion. A range of question typeswere used to identify facts, appropri-
ate actions, and explanations. Participants were alternately allocated
to answer questions about voriconazole or aminophylline first. No
time limit was applied. On completion of the closed questions,
semistructured interviews (Supplementary File 2, http://links.lww.
com/JPS/xxx) were conducted to explore each nurse’s opinion of
the content, design, and wording of the IMG guidelines. The inter-
viewswere audio recorded and field notesweremade. Four pilot in-
terviews were used to refine these techniques.
Analysis and Guideline Revision
The number of participants in each round able to both find and
understand each of the 17 important points of information was de-
termined by scoring against prespecified criteria (Supplementary
File 2, http://links.lww.com/JPS/xxx). A response was scored
“found with ease” if the participant located at least part of the re-
quired information. If the participant took more than 60 seconds
or required 2 or more prompts, it was scored “found with diffi-
culty.” If a participant did not locate any of the required
TABLE 1. The 8 Facets of Rosenbaum’s User Experience Framework22
Facet Definition
Accessibility Are there physical barriers to users gaining access to the document?
Findability Can users locate what they are looking for?
Usefulness Does the document have practical value for users?
Usability How easy and satisfying is the document to use?
Understandability This covers 2 types of comprehension:
Do users understand what type of document they are looking at?
Do users correct understand the content of the document in the way that the author intended?
Credibility Is the document trustworthy?
Desirability Is the document something the user wants or has a positive emotional response to?
Affiliation Do users believe the document is intended to be used by “someone like me”?
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information, the response was scored “not found.” Responses
were scored “understood” if the participant interpreted the infor-
mation located to give the complete prespecified answer. Partial
answers and incorrect calculations were scored “not understood.”
Where a response was scored “not found,” understanding was
scored as “not applicable.”
Interview recordings were transcribed and anonymized, then
analyzed using thematic analysis based on the 6 stages described
by Braun and Clarke.23 The aim was to produce a detailed account
of views that would help improve the performance of the IMG. A
mixed inductive and deductive approach using Rosenbaum’s user
experience framework21 was used to ensure that all aspects of par-
ticipants’ experience of the IMG were explored. Transcripts were
read and potential emerging codes were noted. Transcripts were
coded in Nvivo (Version 11; QSR International). Codes were re-
viewed and sorted into the 8 facets of the Rosenbaum user experi-
ence framework (Table 1), while also grouping codes that did not
fit the framework into emerging themes. Codes and themes were
refined iteratively to produce a descriptive account of the data.
After each round of user testing, the IMG guidelines were re-
vised based on the participants’ responses and information
design best practice.24–26 To ensure acceptability, changes were
discussed with the advisory group. Revised guidelines were
tested in the subsequent round.
Ethics Approval
This study was approved by the University of Bath Research
Ethics Approvals Committee for Health (Reference Number
EP17/18-126) and the NHS Health Research Authority (IRAS
Number 235214).
RESULTS
Thirty nurses with experience in a wide range of clinical areas
participated (Table 3).
Round 1 Closed Questions and Guideline Revisions
In round 1, fewer than half of the closed questions were answered
correctly by all participants (Table 4). Question (Q) 7 (relating to
voriconazole dose measurement) and Q12 (aminophylline adverse
effects) were the questions for which information was most often
not found. For Q7, many participants did not locate the voriconazole
displacement volume and thus used an incorrect drug concentration.
TABLE 2. Closed Questions About Voriconazole (“Bathicillin”) and Aminophylline (“Unimycin”)
1 How is intravenous bathicillin supplied?
2 Imagine you are reconstituting 200 mg of bathicillin. What do you need to use?
3 What infusion solutions can be used to dilute reconstituted bathicillin solution?
4 What should be monitored before starting a patient on bathicillin?
5 Suppose you are preparing a dose of 600 mg of bathicillin. What size infusion bag should be used?
6 How much sodium does the B-Cil brand of bathicillin contain?
7 Imagine you are making an infusion of 270 mg of bathicillin. How much reconstituted solution should you add to the infusion bag?
8 Can you give bathicillin to a patient who is allergic to latex?
9 Imagine you were giving a dose of 420 mg of bathicillin to a patient weighing 70 kg. What’s the shortest time the infusion should last?
10 In general, in what different ways can a dose of intravenous unimycin be given and why?
11 Round 1*:
Suppose you were programming an infusion pump for a continuous infusion of unimycin at a rate of 700 μg/kg per hour for a patient
weighing 65 kg. What infusion rate do you require in milliliter per hour?
Rounds 2 and 3*:
Suppose you were programming an infusion pump for a continuous infusion of unimycin at a rate of 45.5 mg/h. What infusion rate
do you require in milliliters per hour?
12 What should you do if a patient develops low blood pressure while being given unimycin
13 Can you give an infusion of ciprofloxacin at the same time as an infusion of unimycin through the same cannula?
14 Suppose you prepare a continuous infusion of unimycin at 1 pm on Monday. What is the latest time you must stop using this infusion?
15 Why is extravasation of unimycin likely to be harmful?
16 Why is it important to double check the correct dose of unimycin has been prescribed?
17 What must you do if you need to give undiluted unimycin injection?
*As described in Table 5, after round 1, we revised the description of unimycin infusion rates in the guide, to ensure that it was aligned with users’ needs.
This necessitated a change to question 11.
TABLE 3. Participant Characteristics (n = 30 Overall, n = 10 in Each Round)
No. Female
Participants
Median Age
(Interquartile
Range)
No. Participants From
Each Hospital Median Years
Nursing Experience
(Interquartile Range)
Median Percentage
of Shifts in Which Intravenous
Medicines Administered
(Interquartile Range)
Number With
English as First
Language1 2 3
Round 1 9/10 32 (25–48) 5 2 3 7 (3–12) 100 (88–100) 7/10
Round 2 8/10 32 (26–45) 2 6 2 5 (3–9) 100 (98–100) 9/10
Round 3 10/10 38 (25–44) 2 3 5 7 (2–19) 100 (94–100) 8/10
Overall 27/30 33 (26–45) 9 11 10 6 (3–12) 100 (94–100) 24/30
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Question 5 (voriconazole infusion bag size), Q9 (voriconazole in-
fusion time), and Q11 (aminophylline infusion rate) had the most
commonly misunderstood information, all of which were related
to calculation errors.
Numerous changes were made to the wording, structure, and
design of the IMG guidelines (Supplementary File 3, http://links.
lww.com/JPS/A331) to address the problems identified through
both the closed questions and the semistructured interviews. Re-
moval of unnecessary words, and addition of bullet points, active
voice, and bold text for emphasis (instead of capitals) were among
the changes made. Revisions related to participants’ difficulties
with calculations are summarized in Table 5.
Participants were observed to use subsection titles to locate the
information they required. Therefore, subsection titles were
changed from capitals to sentence case to improve readability24
and highlighted with a page-width colored bar to ensure clear dif-
ferentiation between subsections. In addition, a number of new
subsections were introduced. Participants found it difficult to find
information on pretreatment checks for both medicines (Q4 and
Q16) as this information was not presented at the start of each
guideline, where they said they expected to find it. A “Before
Treatment” subsection was therefore created. A new “Administra-
tion” subsection was also created, to avoid the need to scroll from
the preparation information to the top of the document for admin-
istration guidance. Participants requested a summary of key infor-
mation for each medicine, as detailed information is not required
for most patients. Therefore, a “Summary” was added to the start
of each guideline.
Advice on managing acute adverse effects of aminophylline
was moved from the “method of administration” subsection to
the “adverse effects and monitoring” subsection, where partici-
pants expected it to be located (Q12).
Round 2 Closed Questions and Guideline Revisions
The number of participants able to find and understand the in-
formation required increased when the revised monographs were
tested in round 2 (Table 4). Information remained not found most
often for Q7 (voriconazole dose measurement), although more
people found the necessary information than in round 1. Once
again, this was because participants did not account for the dis-
placement volume. The only closed questions for which informa-
tion was misunderstood were Q7 and Q9 (voriconazole infusion
time). In each case, one participant made a calculation error.
After completion of round 2, fewer revisionswere required (Sup-
plementary File 4, http://links.lww.com/JPS/A332). To address the
problems related to Q7 (voriconazole dose measurement), the de-
scription of the concentration of reconstituted voriconazole solu-
tion was moved into the same bullet as the description of
reconstitution, as many round 2 participants did not read as far
as the concentration description. Several participants stated that
they did not recognize the concentration description (“10 mg in
TABLE 4. Number of Participants in Each Round Scored as Finding and Understanding the Information Needed to Answer Each of
the 17 Closed User Testing Questions
Question
Information Found With Ease* Information Found With Difficulty† Found and Understood‡
Round 1
(n = 10)
Round 2
(n = 10)
Round 3
(n = 10)
Round 1
(n = 10)
Round 2
(n = 10)
Round 3
(n = 10)
Round 1§
(n = 10)
Round 2§
(n = 10)
Round 3§
(n = 10)
1 10 10 10 0 0 0 10 10 10
2 9 10 10 1 0 0 10 10 10
3 10 10 10 0 0 0 10 10 10
4 5 8 10 4 2 0 9 10 10
5 1 10 10 6 0 0 3 10 10
6 10 9 10 0 1 0 10 10 10
7 2 4 5 1 1 4 3 4 8
8 9 10 10 1 0 0 10 10 10
9 5 9 9 5 1 1 6 9 9
10 10 10 10 0 0 0 8 10 10
11 3 6 5 7 4 5 7 10 10
12 2 10 10 2 0 0 4 10 10
13 10 10 10 0 0 0 10 10 10
14 9 9 7 1 1 3 10 10 10
15 10 10 10 0 0 0 9 10 10
16 5 7 9 1 2 1 5 9 10
17 5 6 6 5 4 4 10 10 10
*As described in themethods section, a response was scored as “foundwith ease” if the participant located at least part of the required information in less
than 60 seconds and with fewer than 2 prompts.
†As described in the methods section, a response was scored as “found with difficulty” if the participant located the first part of the required information
in more than 60 seconds or with 2 or more prompts. In the results, all participants scored as finding information “with difficulty” took more than 60 seconds
to locate the required information, although 8 participants also required 2 prompts.
‡As described in the methods section, responses were scored as “understood” if the participant interpreted the information located to give the complete
prespecified answer. Data are presented for the number of participants finding and understanding, as finding information is a prerequisite of understanding
it, so participants who could not find information were scored “not applicable” for understanding.
§As there were 10 participants in each round, a number less than 10 indicates that some participants were unable to find and understand the required
information.
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1 mL”) as relevant, as they were considering 200 mg
reconstituted with 19 mL. Therefore, the description of this con-
centration was changed to “20 mL containing 200 mg.” To ad-
dress the problems with Q9 (voriconazole infusion time), the
link to the table of infusion times was made more prominent. Fi-
nally, the “summary” subsection added at the end of round 1 was
removed, because most participants stated that there were too
many subheadings and they would not read beyond the summary,
so they would be concerned that they would not read potentially
important advice. In addition, the summary attracted attention,
so participants reported being less likely to notice smaller subsec-
tions nearby. In place of the summary, darker bars for the “prepara-
tion” and “administration” subsection headings were introduced, to
alert users to the location of this key information.
Round 3 Closed Questions and Guideline Revisions
The guidelines tested in round 3 performed better overall than
those tested in round 2 (Table 4). More participants were able
to find and understand the information required. Question 7
(voriconazole dose measurement) was still the closed question
for which the fewest participants (8 of 10) found and under-
stood the required information, but this was improved com-
pared with round 2.
Limited changes were made to the IMG guidelines after
round 3 (Supplementary File 5, http://links.lww.com/JPS/
A333). An equation for calculating the required volume of
reconstituted voriconazole solution was added, as one participant
had located the drug concentration but was unsure how to use it,
while another had not accounted for the displacement volume.
To ensure familiarity to typical users, this equation was written
in the form described by many participants.
Overall Performance of the Guidelines
Figure 1 summarizes the overall performance of the IMG
guidelines and shows that by identifying problems with the IMG
guidelines and introducing revised designs, the user testing pro-
cess improved their performance. During round 1 there were 36
cases (of a potential 340) of a participant being unable to find or
understand an important point of information, compared with
only 3 cases during round 3.
Participants’ Opinions of Content, Design,
and Wording
Codes relating to all 8 facets of Rosenbaum’s user experience
framework were identified. The 6 facets most relevant to the aims
of this study are described hereinafter.
Facet 1: Affiliation
Participants in all rounds clearly felt that the guidelines tested
were intended to be used by someone performing their profes-
sional role. This especially applied to the first half of each
guideline (Table 6, quotation 1). Two reasons were given: the
content was relevant to the tasks they had to perform and the
language was appropriate. However, some round 1 participants
also suggested that the guidelines were intended to be used
by someone with more reading time than is typically available
(Table 6, quotation 2). The absence of similar comments in
later rounds may suggest that the revisions were successful in
this respect.
Facet 2: Credibility
Participants identified a range of IMG features affecting credi-
bility. These included lists of references and suppliers, as well as
comprehensive and clear content in rounds 2 and 3. A number
of features suggested in round 1 were introduced in round 2 (e.g.,
prominent publication date and NHS branding), where participants
commented that they increased credibility.
Facet 3: Findability
Across all 3 rounds, participants commented that highlighting
key information with bold text and subheadings increased
findability. Many participants found the revised subheading de-
sign in rounds 2 and 3 aided findability (Table 6, quotation 3).
Participants expected the guidelines to be presented in the order
in which the information is needed while preparing a medicine.
Participants in round 1 described various problems with the order
of the information (Table 6, quotation 4). Some participants in all
rounds felt that the information was presented in the right
order, but this became progressively more common through
the 3 rounds (Table 6, quotation 5).
TABLE 5. Participants’ ProblemsWith Calculations Identified During Round 1 and the Consequent Guide RevisionsMade Before Round 2
Direct Question Round 1 Problem Guide Revision Before Round 2
Q5: Suppose you are preparing a dose of
600 mg of bathicillin. What size infusion
bag should be used?
Three participants did not find the voriconazole
concentration range required to answer this
question. Four further participants could
not use this information to calculate the
correct answer
Provide suggested dilution volumes instead
of a concentration range, thus removing
the need for a calculation
Q7: Imagine you are making an infusion of
270 mg of bathicillin. How much
reconstituted solution should you add to
the infusion bag?
Seven participants did not account for the
displacement volume of voriconazole
Use bold text and bullet points to emphasize
the concentration of the reconstituted
solution.
Q9: Imagine you were giving a dose of
420 mg of bathicillin to a patient
weighing 70 kg. What’s the shortest time
the infusion should last?
Four participants could not perform the
calculation needed to answer this question
Provide an equation and table to calculate
the infusion rate
Q11: Suppose you were programming an
infusion pump for a continuous infusion
of unimycin at a rate of 700 μg/kg per hour
for a patient weighing 65 kg. What infusion
rate do you require in milliliter per hour?
Participants stated that weight-based infusion
rate calculations were not relevant to their
practice, as weight-based calculations were
performed by prescribers
Move this information to a new “example dose
calculation” subsection, and add an equation
and example calculation linking infusion rate,
prescribed dose and concentration
J Patient Saf • Volume 00, Number 00, Month 2020 User Testing Medicines Guidelines
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Participants in all rounds described using a search strategy
based on subheadings (Table 6, quotation 6). However, participants
in round 1 found that they needed to scroll through a lot of
information to find what they needed. This was viewed
negatively (as it caused delay) and was linked to difficulty
knowing where to find certain information. A range of specific
types of information were described as easy to find across all
the rounds. Conversely, some types of information were described
as hard to find, including adverse effects, the “before treatment”
subsection and drug concentrations. These comments were
mainly in round 1.
Facet 4: Understandability
In round 1, participants commented that although they under-
stood most of the content, some of it could be improved and they
sometimes needed help from a colleague (Table 6, quotation 7).
More in rounds 2 and 3 thought that the content of the
FIGURE 1. The number of closed questions (n = 17) in each round of user testing which achieved variousmeasures of overall performance. As
described in the methods section, a response was scored as “found with ease” if the participant located at least part of the required
information. If the participant tookmore than 60 seconds or required 2 ormore prompts, it was scored “foundwith difficulty.” Responseswere
scored as “understood” if the participant interpreted the information located to give the complete prespecified answer.
TABLE 6. Selected Quotations From the Semi-Structured Interviews
Quotation (Participant Number) Round Sex
Years of
Experience Hospital
1 “I think so, I think definitely the first part would definitely be aimed at a nurse who
was preparing and administering these. As I said before there is parts of the second
part that I just do not think would be relative to nursing staff.” (A19)
2 Female 3 2
2 “… they are presuming you have half an hour to read all this before you are dishing the
drug out which in an ideal world you would…” (A8)
1 Female 2.5 1
3 “… and use of the big blue lines is breaking it down to bits that I need. I think it will be
easier to click through the screen and find the information that I need simply because
it seems separated.” (A18)
2 Male 4.5 2
4 “… there is preparation and administration isn't there, there is the 2 different parts of it,
you prep a drug and then you go and administer it so I suppose there, even though it is
good having the times at the top you almost want your preparation bit first and then your
method of actually administering and the prep would be the reconstitution and then which
bag to put it in.” (A11)
1 Female 9 1
5 “… it is laid out in a way that it’s a natural progression of this is what I want, how am I
making it, how am I giving it?” (A33)
3 Female 2 1
6 “… I think if you read the whole thing from start to finish all the information is there isn't it but
no one does that, you skip down for the heading you are looking for don't you.” (A11)
1 Female 9 1
7 “It’s there, sometimes I feel it’s not worded the right way and I confuse myself and I have to
double check with colleagues or pharmacy, but it is there.” (A5)
1 Female 5 1
8 “It is quite clear, it is very specific which is good.” (A15) 2 Female 3 2
9 “… there is too many words and it’s too complicated. Which when you are giving IVs you
want a very simple and you want it very obvious, if there is this amount of writing…it can
take you 20 minutes to actually find all the information, that’s where your errors hop in,
because it’s not obvious.” (A13)
1 Female 31 3
10 “There always seems to be a lot of writing but that is because there is a lot of information
that has got to be put over” (A8)
1 Female 3 1
11 “They were really useful, they are probably the most in depth prompt I have seen. Normally we just
get a page of the basics… but it has got all the information and it is quite clearly laid out from…the
order you would do it in.” (A31)
3 Female 2 3
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guidelines was easy to understand. Participants suggested that
specific, detailed, and practical instructions helped make guidelines
more understandable, while excessive wordiness made them less
understandable (Table 6, quotations 8 and 9).
Facet 5: Usability
Participants in all rounds, especially rounds 2 and 3,
commented that the guidelines were generally clear and easy to
use. However, some in rounds 1 and 2 held more nuanced opin-
ions: although the guidelines were usable, this could be improved,
or that the guidelines were easy to use once they were familiar.
Some participants thought that the guidelines presented an over-
whelming amount of information; however, there was recognition
that this was necessary (Table 6, quotation 10).
Facet 6: Usefulness
Participants (especially in rounds 2 and 3) thought that the
guidelines would be of practical use in their daily practice. How-
ever, some participants in round 1 and one in round 2 commented
that although the guidelines were useful, this could be improved.
Many participants in all rounds commented that the guidelines
were useful because they provided comprehensive information
and specific detail (Table 6, quotation 11). Participants in all
rounds commented on the usefulness of the different types of
information contained within the guidelines. Some participants
commented that all the information would be useful. Many
types of information were highlighted as being particularly
important or unimportant with considerable overlap between
these 2 conflicting lists.
Participants in rounds 2 and 3 commented that it was easier to
find information in the guideline they tested and that it was more
understandable and usable, compared with the current IMG.
DISCUSSION
This study reports only the second application of user testing as
a tool to improve the retrieval and comprehension of written med-
icines information for health professionals. It is the first such
study of guidelines for nurses about safe medicines administra-
tion. Despite the current use of the IMG in everyday practice,
the results demonstrated that many practicing nurses were unable
to find and/or understand important points of information. By
identifying these problems and potential solutions, user testing
improved the performance of the guidelines, such that by round
3, there were only 3 instances of a participant being unable to find
or understand an important point of information.
The results of this study are comparable with those of Raynor
et al,11 who applied user testing with doctors to improve the pre-
sentation of SPCs for 2 medicines. Both studies resulted in similar
changes to the information under investigation (e.g., use of bullet
points and bold text, new subsections, and moving information to
make it easier to find). Information retrieval and comprehension
improved after user testing in both studies; however, performance
of the final documents in the current study was better than that of
Raynor et al.11 This may be because SPCs are longer documents
that cover a greater range of complex topics. This could also ex-
plainwhy a summary sectionwas deemed useful byRaynor et al,11
but not in the present study. Similarly, the application of user test-
ing to nonmedicines guidance for health professionals has also re-
sulted in improved document performance by resolving similar
difficulties to those identified in this study (e.g., lack of specific
detail and difficulty interpreting numerical information).14–16
To the best of our knowledge, this is the first study to examine
the application of user testing to improve the performance of med-
icines guidance for nurses. Among other strengths of this study
are the use of new participants in each round and guideline
anonymization, to minimize learning effects. However, the princi-
pal limitation of this study is that the performance of the IMG
guidelines was tested in an interview rather than in clinical prac-
tice. Therefore, the next stage of our research will be to find out
whether use of the revised guidelines results in fewer errors in
preparation and administration of intravenous medicines in a clin-
ical environment. In addition, the IMG includes information on
hundreds of medicines, so it is unclear whether these findings
would be replicated with other medicines, such as those that are
simpler to prepare and administer. However, many of the revisions
introduced in this study (e.g., subsection title design, new subsec-
tions, increased support for calculations) could be applied to any
medicine in the IMG.
This study has demonstrated that key points of information in
medicines guidelines may not be found and understood by health
professionals, even when they have been written using a quality
assurance process to ensure accuracy and comprehensiveness.18
As the points of information that were not found and/or under-
stood in this study related to key steps in the preparation and ad-
ministration of intravenous medicines (e.g., measuring the
correct dose and infusing it at the right rate), such problems with
the design of guidelines might increase the risk of serious errors.
Authors should therefore ensure that healthcare professional med-
icines guidelines are usable for their target readers, as well as be-
ing accurate and comprehensive. User testing can help achieve
this, as it improved the performance of the guidelines and may
therefore increase medicines safety by improving the quality of
professional guidelines, a recognized cause of medication er-
rors.5,6 User tested patient medicines information is a requirement
for licensed medicines.12 An additional requirement for manufac-
turers to supply user tested professional medicines information in
a standard format might reduce the need for healthcare providers
to produce bespoke guidance such as the IMG.
As the effectiveness of user testing medicines guidelines for
health professionals has been examined only twice, future re-
search should test different types of medicines information (e.g.,
the British National Formulary or locally produced guidelines)
and groups of health professionals (e.g., pharmacists).
CONCLUSIONS
Healthcare professionals may not be able to find and under-
stand key topics in written medicines guidelines used in everyday
practice. However, user testing can improve both the retrieval and
comprehension of information.
ACKNOWLEDGMENTS
The research team acknowledges the support of the National
Institute for Health Research Clinical Research Network (NIHR
CRN) and would like to thank the participants, lay advisors and
members of the professional advisory group for their important
contributions to this study.
REFERENCES
1. Elliott RA, Camacho E, Campbell F, et al. Prevalence and economic burden
of medication errors in the NHS in England. Policy Research Unit in
Economic Evaluation of Health and Care Interventions. 2018. Available at:
http://www.eepru.org.uk/prevalence-and-economic-burden-of-medication-
errors-in-the-nhs-in-england-2/. Accessed June 4, 2020.
2. Medication Without Harm - Global Patient Safety Challenge on
Medication Safety. Geneva: World Health Organization; 2017.
3. Keers RN, Williams SD, Cooke J, et al. Prevalence and nature of
medication administration errors in health care settings: a systematic review
of direct observational evidence. Ann Pharmacother. 2013;47:237–256.
J Patient Saf • Volume 00, Number 00, Month 2020 User Testing Medicines Guidelines
© 2020 The Author(s). Published by Wolters Kluwer Health, Inc. www.journalpatientsafety.com 7
4. McLeod MC, Barber N, Franklin BD. Methodological variations and their
effects on reported medication administration error rates. BMJ Qual Saf.
2013;22:278–289.
5. Lawton R, McEachan RR, Giles SJ, et al. Development of an
evidence-based framework of factors contributing to patient safety
incidents in hospital settings: a systematic review. BMJ Qual Saf. 2012;21:
369–380.
6. Chang A, Schyve PM, Croteau RJ, et al. The JCAHO patient safety event
taxonomy: a standardized terminology and classification schema for near
misses and adverse events. International J Qual Health Care. 2005;17:
95–105.
7. Cousins DH, Sabatier B, Begue D, et al. Medication errors in
intravenous drug preparation and administration: a multicentre audit
in the UK, Germany and France. Qual Saf Health Care. 2005;14:
190–195.
8. Taxis K, Barber N. Causes of intravenous medication errors: an
ethnographic study. Qual Saf Health Care. 2003;12:343–348.
9. Keers RN, Williams SD, Cooke J, et al. Understanding the causes of
intravenous medication administration errors in hospitals: a qualitative
critical incident study. BMJ Open. 2015;5:e005948.
10. Dornan T, Ashcroft D, Heathfield H, et al. An in depth investigation
into causes of prescribing errors by foundation trainees in relation to
their medical education. EQUIP Study. General Medical
Council; 2009.
11. Raynor DK, Veene PD, Bryant D. The effectiveness of the summary of
product characteristics (SmPC) and recommendations for improvement.
Ther Innov Regul Sci. 2013;48:255–265.
12. Raynor DK, Knapp P, Silcock J, et al. “User-testing” as a method for testing
the fitness-for-purpose of written medicine information. Patient Educ
Couns. 2011;83:404–410.
13. Raynor DK, Blackwell K, Middleton W. What do writers need to know
about user testing?Med Writing. 2015;24:215–218.
14. Rosenbaum SE, Glenton C, Oxman AD. Summary-of-findings tables in
Cochrane reviews improved understanding and rapid retrieval of key
information. J Clin Epidemiol. 2010;63:620–626.
15. Verhoeven F, Steehouder MF, Hendrix RM, et al. From expert-driven to
user-oriented communication of infection control guidelines. Int J
Hum-Comput St. 2010;68:328–343.
16. Rosenbaum SE, Glenton C, Nylund HK, et al. User testing and stakeholder
feedback contributed to the development of understandable and useful
summary of findings tables for Cochrane reviews. J Clin Epidemiol. 2010;
63:607–619.
17. Gagliardi AR, Marshall C, Huckson S, et al. Developing a checklist for
guideline implementation planning: review and synthesis of guideline
development and implementation advice. Implement Sci. 2015;10:19.
18. NHS InjectableMedicines Guide Group. NHS InjectableMedicines Guide.
Available at: www.medusa.wales.nhs.uk. Accessed December 23, 2019.
19. Erskine D, Haylor J, Keeling S, et al. An assessment of the information
provided to support healthcare staff to administer injectable medicines.
UKMi Practice Development Seminar. 2014. Birmingham. Available at:
https://www.ukmi.nhs.uk/NonCMS/conferenceDB2014/Documents/
postersandpresentations/19%20Erskin%20D%20Medusa%20poster%
202014%20final.pdf. Accessed June 4, 2020.
20. Skipp M, Templeman E. A survey to determine how the medusa injectable
medicines guide is used within the south west. UKMi Practice
Development Seminar. 2016. Birmingham.
21. Rosenbaum S. Improving the User Experience of Evidence [dissertation].
The Oslo School of Architecture and Design; 2010.
22. Sless D. Designing public documents. Inf Des J. 2004;12:24–35.
23. Braun V, Clarke V. Using thematic analysis in psychology. Qual Res
Psychol. 2006;3:77–101.
24. Raynor DK, Dickinson D. Key principles to guide development of
consumer medicine information—content analysis of information design
texts. Ann Pharmacother. 2009;43:700–706.
25. Genova J, Nahon-Serfaty I, Dansokho SC, et al. The Communication
AssessmenT Checklist in Health (CATCH): a tool for assessing the quality
of printed educational materials for clinicians. J Contin Educ Health Prof.
2014;34:232–242.
26. Versloot J, Grudniewicz A, Chatterjee A, et al. Format guidelines to make
them vivid, intuitive, and visual. Int J Evid Based Healthc. 2015;13:52–57.
Jones et al J Patient Saf • Volume 00, Number 00, Month 2020
8 www.journalpatientsafety.com © 2020 The Author(s). Published by Wolters Kluwer Health, Inc.
